Иммунология и аллергология
1157 статей · 37 журналов
Журналы подкатегории (37)
- Transplantation and Cellular Therapy · Elsevier (102)
- Journal of Global Antimicrobial Resistance · Elsevier (94)
- The Journal of Allergy and Clinical Immunology: In Practice · Elsevier (93)
- Allergy: European Journal of Allergy and Clinical Immunology · Wiley (90)
- Journal of Allergy and Clinical Immunology · Elsevier (89)
- Annals of Allergy, Asthma & Immunology · Elsevier (87)
- Allergology International · Elsevier (71)
- Journal of Allergy and Clinical Immunology: Global · Elsevier (71)
- International Forum of Allergy and Rhinology · Wiley (67)
- Immunology and Allergy Clinics of North America · Elsevier (58)
- Contact Dermatitis · Wiley (57)
- Hematology, Transfusion and Cell Therapy · Elsevier (55)
- Immunobiology · Elsevier (51)
- Human Immunology · Elsevier (41)
- Immunology Letters · Elsevier (31)
- Neuroimmunology Reports · Elsevier (21)
- Revue Française d'Allergologie · Elsevier (21)
- World Allergy Organization Journal · Elsevier (17)
- APMIS · Wiley (14)
- Nature Immunology · Springer Nature (11)
- Mucosal Immunology · Springer Nature (8)
- Nature Reviews Immunology · Springer Nature (8)
- Allergo Journal · Springer Nature (0)
- Allergo Journal International · Springer Nature (0)
- Cancer Immunology, Immunotherapy · Springer Nature (0)
- Clinical Reviews in Allergy & Immunology · Springer Nature (0)
- Clinical and Molecular Allergy · Springer Nature (0)
- Immunity & Inflammation · Springer Nature (0)
- Inflammation · Springer Nature (0)
- Inflammation and Regeneration · Springer Nature (0)
- Journal of Clinical Immunology · Springer Nature (0)
- Journal of Inflammation · Springer Nature (0)
- Journal of Neuroimmune Pharmacology · Springer Nature (0)
- Medical Microbiology and Immunology · Springer Nature (0)
- Rheumatology International · Springer Nature (0)
- Rheumatology and Therapy · Springer Nature (0)
- Seminars in Immunopathology · Springer Nature (0)
- Rethinking Letermovir Strategy Beyond Day +100 for Late CMV Prevention After Allogeneic Hematopoietic Cell Transplantation
- Comment on “Immune Reconstitution After Allogeneic Stem Cell Transplantation: Time Alone Does Not Heal All Wounds”
- An Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients
- Association between anti-thymocyte globulin exposure and clinical outcomes of adult undergoing haploidentical hematopoietic stem cell transplantation with myeloablative conditioning: a pharmacokinetic-guided study
- SEXUAL FUNCTION IN WOMEN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF AN OBSERVATIONAL STUDY
- Impact of Venetoclax Bridging on Haematopoietic Stem Cell Transplantation Outcomes in Advanced Myelodysplastic Neoplasms
- Five-Year Follow-Up of ZUMA-3: A Phase 1/2 Study of Brexucabtagene Autoleucel for the Treatment of Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Infusion timing and outcomes after allogeneic hematopoietic cell transplantation across graft sources
- Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia
- Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma
- Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy
- Sepsis in Chimeric Antigen Receptor T-Cell Therapy: A Six-Year Nationwide Analysis of Clinical Outcomes and Healthcare Resource Utilization in Hospitalizations for Hematologic Malignancies
- Early T-cell Large Granular Lymphocyte Expansions in Patients with Cytopenias after CD19 CAR T-cell Therapy
- Reply to “Does Lower PTCy Dose Increase GVHD?”
- Association of Post-Transplant Cyclophosphamide Dose with BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Cell Transplantation
- Traversing the Last Mile: Bringing Chimeric Antigen Receptor T-Cell Therapy to the Community Setting
- Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience
- Allogeneic CD33/CD123 CAR-T сells in pediatric relapsed/refractory AML: early single-center experience
- The effect of coping strategies on overall survival and other outcomes after allogeneic stem cell transplant
- Caregiver Stress and Coping during Pediatric Hematopoietic Stem Cell Transplant: Perspectives of Caregivers and Healthcare Providers
- Ligand/receptor-based chimeric antigen receptors: a promising alternative to conventional scFv designs in cancer immunotherapy
- Bone marrow niche disruption via interferon gamma-mediated CXCL9/CXCL10 secretion after allogeneic transplantation
- Attrition Factors in Patients with Metastatic Melanoma Screened for Tumor Infiltrating Lymphocyte Therapy
- Severe graft-versus-host disease and limited durable response with mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma
- When cord blood grafts may be the preferred donor choice: a position statement from the ASTCT Cord Blood Special Interest Group
- Invasive fungal infections after moderate or severe chronic graft-versus-host disease in allogeneic hematopoietic cell transplant recipients: incidence, timing, and associated factors
- Model-informed precision dosing of busulfan in Adults: Real world implications for Dosing and Transplant outcomes
- Real-world access and barriers to CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a population-based study
- Comparison of pegfilgrastim and daily G-CSF for CD34+ cell mobilization in healthy donors and post-transplant engraftment: The Pegfilgrastim-23 Study
- A multicenter study of allogeneic HSCT in Nijmegen breakage syndrome with conditioning regimen based on reduced doses of treosulfan